In Brief: CDER Division of Drug Marketing, Advertising & Communications
CDER Division of Drug Marketing, Advertising & Communications: Norman Drezin is appointed deputy director, and Tom Abrams and Leah Palmer are appointed branch chiefs for marketing surveillance and enforcement branches I & II. All three previously held the same positions in an acting capacity. JoAnn Spearmon joins FDA from PHS as a DDMAC regulatory review officer in the anti-infectives area...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth